Defining immune cell phenotypes that distinguish treatment responders and non-responders in RA

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Seminars in arthritis and rheumatism 2025-02, Vol.70, p.152581, Article 152581
Hauptverfasser:	Marks, Kathryne E., Horisberger, Alice, Solomon, Daniel H., Rao, Deepak A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - immunology Humans Personalized medicine Phenotype Rheumatoid arthritis TNF inhibitors Treatment Outcome Treatment response
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page	152581
container_title	Seminars in arthritis and rheumatism
container_volume	70
creator	Marks, Kathryne E. Horisberger, Alice Solomon, Daniel H. Rao, Deepak A.
description
doi_str_mv	10.1016/j.semarthrit.2024.152581
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3130827103</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S004901722400221X</els_id><sourcerecordid>3130827103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1645-7a091adad1887f82526cfbb517b04318efe4d7bac29bdccf466214f0e525f4d53</originalsourceid><addsrcrecordid>eNqFkE1rGzEQhkVpqB23f6HomMs6Gu1Kuz666UcCgUBIIKcKrTSKZbzajaQN5N93jd0kt5wGhued4X0IocCWwECeb5cJOx3zJvq85IxXSxBcNPCJzEGUvGikfPhM5oxVq4JBzWfkNKUtYwCS1V_IrFwJyXkt5uTvT3Q--PBIfdeNAanB3Y4OGwx9fhkw0bzRmVqf8sSMPm1ojqhzhyHTiGnog8WYqA6Whj4U71Y-0Nv1V3Li9C7ht-NckPvfv-4uLovrmz9XF-vrwoCsRFFrtgJttYWmqV3DBZfGta2AumVVCQ06rGzdasNXrTXGVVJyqBzDqbWrrCgX5Oxwd4j904gpq86nfRUdsB-TKqFkDa-BlRPaHFAT-5QiOjVEP8l8UcDU3q7aqje7am9XHexO0e_HL2PboX0N_tc5AT8OAE5dnz1GlYzHYND6iCYr2_uPv_wDfJqSkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130827103</pqid></control><display><type>article</type><title>Defining immune cell phenotypes that distinguish treatment responders and non-responders in RA</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Marks, Kathryne E. ; Horisberger, Alice ; Solomon, Daniel H. ; Rao, Deepak A.</creator><creatorcontrib>Marks, Kathryne E. ; Horisberger, Alice ; Solomon, Daniel H. ; Rao, Deepak A.</creatorcontrib><identifier>ISSN: 0049-0172</identifier><identifier>ISSN: 1532-866X</identifier><identifier>EISSN: 1532-866X</identifier><identifier>DOI: 10.1016/j.semarthrit.2024.152581</identifier><identifier>PMID: 39562275</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - drug therapy ; Arthritis, Rheumatoid - immunology ; Humans ; Personalized medicine ; Phenotype ; Rheumatoid arthritis ; TNF inhibitors ; Treatment Outcome ; Treatment response</subject><ispartof>Seminars in arthritis and rheumatism, 2025-02, Vol.70, p.152581, Article 152581</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1645-7a091adad1887f82526cfbb517b04318efe4d7bac29bdccf466214f0e525f4d53</cites><orcidid>0000-0002-1524-7159 ; 0000-0001-9672-7746</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S004901722400221X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39562275$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marks, Kathryne E.</creatorcontrib><creatorcontrib>Horisberger, Alice</creatorcontrib><creatorcontrib>Solomon, Daniel H.</creatorcontrib><creatorcontrib>Rao, Deepak A.</creatorcontrib><title>Defining immune cell phenotypes that distinguish treatment responders and non-responders in RA</title><title>Seminars in arthritis and rheumatism</title><addtitle>Semin Arthritis Rheum</addtitle><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Arthritis, Rheumatoid - immunology</subject><subject>Humans</subject><subject>Personalized medicine</subject><subject>Phenotype</subject><subject>Rheumatoid arthritis</subject><subject>TNF inhibitors</subject><subject>Treatment Outcome</subject><subject>Treatment response</subject><issn>0049-0172</issn><issn>1532-866X</issn><issn>1532-866X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1rGzEQhkVpqB23f6HomMs6Gu1Kuz666UcCgUBIIKcKrTSKZbzajaQN5N93jd0kt5wGhued4X0IocCWwECeb5cJOx3zJvq85IxXSxBcNPCJzEGUvGikfPhM5oxVq4JBzWfkNKUtYwCS1V_IrFwJyXkt5uTvT3Q--PBIfdeNAanB3Y4OGwx9fhkw0bzRmVqf8sSMPm1ojqhzhyHTiGnog8WYqA6Whj4U71Y-0Nv1V3Li9C7ht-NckPvfv-4uLovrmz9XF-vrwoCsRFFrtgJttYWmqV3DBZfGta2AumVVCQ06rGzdasNXrTXGVVJyqBzDqbWrrCgX5Oxwd4j904gpq86nfRUdsB-TKqFkDa-BlRPaHFAT-5QiOjVEP8l8UcDU3q7aqje7am9XHexO0e_HL2PboX0N_tc5AT8OAE5dnz1GlYzHYND6iCYr2_uPv_wDfJqSkQ</recordid><startdate>202502</startdate><enddate>202502</enddate><creator>Marks, Kathryne E.</creator><creator>Horisberger, Alice</creator><creator>Solomon, Daniel H.</creator><creator>Rao, Deepak A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1524-7159</orcidid><orcidid>https://orcid.org/0000-0001-9672-7746</orcidid></search><sort><creationdate>202502</creationdate><title>Defining immune cell phenotypes that distinguish treatment responders and non-responders in RA</title><author>Marks, Kathryne E. ; Horisberger, Alice ; Solomon, Daniel H. ; Rao, Deepak A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1645-7a091adad1887f82526cfbb517b04318efe4d7bac29bdccf466214f0e525f4d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Arthritis, Rheumatoid - immunology</topic><topic>Humans</topic><topic>Personalized medicine</topic><topic>Phenotype</topic><topic>Rheumatoid arthritis</topic><topic>TNF inhibitors</topic><topic>Treatment Outcome</topic><topic>Treatment response</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marks, Kathryne E.</creatorcontrib><creatorcontrib>Horisberger, Alice</creatorcontrib><creatorcontrib>Solomon, Daniel H.</creatorcontrib><creatorcontrib>Rao, Deepak A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in arthritis and rheumatism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marks, Kathryne E.</au><au>Horisberger, Alice</au><au>Solomon, Daniel H.</au><au>Rao, Deepak A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining immune cell phenotypes that distinguish treatment responders and non-responders in RA</atitle><jtitle>Seminars in arthritis and rheumatism</jtitle><addtitle>Semin Arthritis Rheum</addtitle><date>2025-02</date><risdate>2025</risdate><volume>70</volume><spage>152581</spage><pages>152581-</pages><artnum>152581</artnum><issn>0049-0172</issn><issn>1532-866X</issn><eissn>1532-866X</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39562275</pmid><doi>10.1016/j.semarthrit.2024.152581</doi><orcidid>https://orcid.org/0000-0002-1524-7159</orcidid><orcidid>https://orcid.org/0000-0001-9672-7746</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 0049-0172
ispartof	Seminars in arthritis and rheumatism, 2025-02, Vol.70, p.152581, Article 152581
issn	0049-0172 1532-866X 1532-866X
language	eng
recordid	cdi_proquest_miscellaneous_3130827103
source	MEDLINE; Elsevier ScienceDirect Journals
subjects	Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - immunology Humans Personalized medicine Phenotype Rheumatoid arthritis TNF inhibitors Treatment Outcome Treatment response
title	Defining immune cell phenotypes that distinguish treatment responders and non-responders in RA
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T18%3A17%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20immune%20cell%20phenotypes%20that%20distinguish%20treatment%20responders%20and%20non-responders%20in%20RA&rft.jtitle=Seminars%20in%20arthritis%20and%20rheumatism&rft.au=Marks,%20Kathryne%20E.&rft.date=2025-02&rft.volume=70&rft.spage=152581&rft.pages=152581-&rft.artnum=152581&rft.issn=0049-0172&rft.eissn=1532-866X&rft_id=info:doi/10.1016/j.semarthrit.2024.152581&rft_dat=%3Cproquest_cross%3E3130827103%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3130827103&rft_id=info:pmid/39562275&rft_els_id=S004901722400221X&rfr_iscdi=true